Table 3. EBV seroprevalence and viremia rates in the studied population (N = 673).

Category		Total No.	EBV serology			EBV DNA
			Positive		p-value*	Positive		p-value*
			No. (%)			No. (%)
Gender
	Male	659	645 (97.9)		0.581	347 (52.7)		0.467
	Female	14	14 (100)			6 (42.9)
Nationality
	Qatari	223	218 (97.8)		0.8358	123 (55.2)		0.296
	Male	219	214 (97.7)			112 (51.1)
	Female	4	4 (100)			2 (50)
	Non-Qatari	450	441 (98)			229 (50.9)
	Male	440	431 (97.9)			226 (51.4)
	Female	10	10 (100)			4 (40)
Age Group
	<20–30	176	169 (96)		0.037	79(44.8)		0.009
	31–40	264	257 (97.3)			134(50.76)
	41–50	174	174 (100)			100 (57.5)
	> 51	59	59 (100)			40(67)

* Pearson Chi² p-value